drugset / Trial / NCT00159627

Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).

NCT00159627 ↗

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety of KW-3902IV compared to placebo and to determine the diuretic effect of KW-3902IV compared to placebo in patients hospitalized with volume overload due to CHF who are refractory to high dose diuretic therapy.

Timeline

Start
2004-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject rolofylline Small molecule — Intravenous